High frequency stimulation of subthalamic nucleus results in behavioral recovery by increasing striatal dopamine release in 6-hydroxydopamine lesioned rat

Behavioural Brain Research

Volumn 263, Issue , 2014, Pages 108-114

  He, Zheng ^b,c   Jiang, Yunxia ^b   Xu, Huamin ^a   Jiang, Hong ^a   Jia, Wenting ^a   Sun, Peng ^b   Xie, Junxia ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^b QINGDAO UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

6 Hydroxydopamine; Dopamine; High frequency stimulation; Parkinson's disease; The subthalamic nucleus

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DAMAGE; BRAIN DEPTH STIMULATION; CELL SURVIVAL; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; CYCLIC POTENTIOMETRY; DOPAMINE RELEASE; ELECTRODE IMPLANT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MICROELECTRODE; MOTOR DYSFUNCTION; NISSL STAINING; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUBSTANTIA NIGRA PARS COMPACTA; SUBTHALAMIC NUCLEUS; SYMPTOMATOLOGY; UPREGULATION; WESTERN BLOTTING; ANIMAL; DOPAMINERGIC NERVE CELL; EXTRACELLULAR SPACE; FEMALE; METABOLISM; MOTOR ACTIVITY; PARKINSONIAN DISORDERS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SUBSTANTIA NIGRA; WISTAR RAT;

ANIMALS; CELL SURVIVAL; CORPUS STRIATUM; DEEP BRAIN STIMULATION; DOPAMINE; DOPAMINERGIC NEURONS; EXTRACELLULAR SPACE; FEMALE; MOTOR ACTIVITY; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, WISTAR; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; TYROSINE 3-MONOOXYGENASE;

EID: 84896727923     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.01.014     Document Type: Article

References (47)

1. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations. J Neurol Sci 1973, 20:415-455.
2. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442.
3. Hornykiewicz O., Kish S.J. Biochemical pathophysiology of Parkinson's disease. Adv Neurol 1987, 45:19-34.
4. Weaver F.M., Follett K., Stern M., Hur K., Harris C., Marks W.J., et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009, 301:63-73.
5. Krack P., Batir A., Van Blercom N., Chabardes S., Fraix V., Ardouin C., et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003, 349:1925-1934.
6. Schupbach W.M., Chastan N., Welter M.L., Houeto J.L., Mesnage V., Bonnet A.M., et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry 2005, 76:1640-1644.
7. Keitel A., Wojtecki L., Hirschmann J., Hartmann C.J., Ferrea S., Sudmeyer M., et al. Motor and cognitive placebo-/nocebo-responses in Parkinson's disease patients with deep brain stimulation. Behav Brain Res 2013, 250:199-205.
8. Benabid AL, Koudsie A, Benazzouz A, Vercueil L, Fraix V, Chabardes S, et al. Deep brain stimulation of the corpus luysi (subthalamic nucleus) and other targets in Parkinson's disease. Extension to new indications such as dystonia and epilepsy. J Neurol 2001;248(Suppl. 3):III37-47.
9. Romito L.M., Contarino M.F., Ghezzi D., Franzini A., Garavaglia B., Albanese A. High frequency stimulation of the subthalamic nucleus is efficacious in Parkin disease. J Neurol 2005, 252:208-211.
10. Li X.H., Wang J.Y., Gao G., Chang J.Y., Woodward D.J., Luo F. High-frequency stimulation of the subthalamic nucleus restores neural and behavioral functions during reaction time task in a rat model of Parkinson's disease. J Neurosci Res 2010, 88:1510-1521.
11. Benabid A.L., Pollak P., Louveau A., Henry S., de Rougemont J. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol 1987, 50:344-346.
12. Siegfried J., Lippitz B. Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery 1994, 35:1126-1129. [discussion 9-30].
13. Benabid A.L., Pollak P., Gross C., Hoffmann D., Benazzouz A., Gao D.M., et al. Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease. Stereotact Funct Neurosurg 1994, 62:76-84.
14. Windels F., Bruet N., Poupard A., Feuerstein C., Bertrand A., Savasta M. Influence of the frequency parameter on extracellular glutamate and gamma-aminobutyric acid in substantia nigra and globus pallidus during electrical stimulation of subthalamic nucleus in rats. J Neurosci Res 2003, 72:259-267.
15. Weaver F.M., Follett K.A., Stern M., Luo P., Harris C.L., Hur K., et al. Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology 2012, 79:55-65.
16. Gervais-Bernard H., Xie-Brustolin J., Mertens P., Polo G., Klinger H., Adamec D., et al. Bilateral subthalamic nucleus stimulation in advanced Parkinson's disease: five year follow-up. J Neurol 2009, 256:225-233.
17. Tan S.K., Janssen M.L., Jahanshahi A., Chouliaras L., Visser-Vandewalle V., Lim L.W., et al. High frequency stimulation of the subthalamic nucleus increases c-fos immunoreactivity in the dorsal raphe nucleus and afferent brain regions. J Psychiatr Res 2011, 45:1307-1315.
18. Meissner W., Reum T., Paul G., Harnack D., Sohr R., Morgenstern R., et al. Striatal dopaminergic metabolism is increased by deep brain stimulation of the subthalamic nucleus in 6-hydroxydopamine lesioned rats. Neurosci Lett 2001, 303:165-168.
19. Meissner W., Harnack D., Paul G., Reum T., Sohr R., Morgenstern R., et al. Deep brain stimulation of subthalamic neurons increases striatal dopamine metabolism and induces contralateral circling in freely moving 6-hydroxydopamine-lesioned rats. Neurosci Lett 2002, 328:105-108.
20. Montgomery E.B. Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology 2003, 60:886-887. [author reply - 7].
21. Pahwa R., Wilkinson S.B., Overman J., Lyons K.E. Preoperative clinical predictors of response to bilateral subthalamic stimulation in patients with Parkinson's disease. Stereotact Funct Neurosurg 2005, 83:80-83.
22. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2007, sixth edition.
23. Earl C.D., Reum T., Xie J.X., Sautter J., Kupsch A., Oertel W.H., et al. Foetal nigral cell suspension grafts influence dopamine release in the non-grafted side in the 6-hydroxydopamine rat model of Parkinson's disease: in vivo voltammetric data. Exp Brain Res 1996, 109:179-184.
24. Jiang H., Luan Z., Wang J., Xie J. Neuroprotective effects of iron chelator Desferal on dopaminergic neurons in the substantia nigra of rats with iron-overload. Neurochem Int 2006, 49:605-609.
25. Jiang H., Song N., Wang J., Ren L.Y., Xie J.X. Peripheral iron dextran induced degeneration of dopaminergic neurons in rat substantia nigra. Neurochem Int 2007, 51:32-36.
26. Junxia X., Hong J., Wenfang C., Ming Q. Dopamine release rather than content in the caudate putamen is associated with behavioral changes in the iron rat model of Parkinson's disease. Exp Neurol 2003, 182:483-489.
27. Zhou Y., Zhao Z.Q., Xie J.X. Effects of isatin on rotational behavior and DA levels in caudate putamen in Parkinsonian rats. Brain Res 2001, 917:127-132.
28. Bruet N., Windels F., Bertrand A., Feuerstein C., Poupard A., Savasta M. High frequency stimulation of the subthalamic nucleus increases the extracellular contents of striatal dopamine in normal and partially dopaminergic denervated rats. J Neuropathol Exp Neurol 2001, 60:15-24.
29. Benabid A.L., Chabardes S., Mitrofanis J., Pollak P. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol 2009, 8:67-81.
30. Breit S., Schulz J.B., Benabid A.L. Deep brain stimulation. Cell Tissue Res 2004, 318:275-288.
31. Lindemann C., Krauss J.K., Schwabe K. Deep brain stimulation of the subthalamic nucleus in the 6-hydroxydopamine rat model of Parkinson's disease: effects on sensorimotor gating. Behav Brain Res 2012, 230:243-250.
32. Molinuevo J.L., Valldeoriola F., Tolosa E., Rumia J., Valls-Sole J., Roldan H., et al. Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease. Arch Neurol 2000, 57:983-988.
33. Moro E., Scerrati M., Romito L.M., Roselli R., Tonali P., Albanese A. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease. Neurology 1999, 53:85-90.
34. Kern D.S., Kumar R. Deep brain stimulation. Neurologist 2007, 13:237-252.
35. Zhao X.D., Cao Y.Q., Liu H.H., Li F.Q., You B.M., Zhou X.P. Long term high frequency stimulation of STN increases dopamine in the corpus striatum of hemiparkinsonian rhesus monkey. Brain Res 2009, 1286:230-238.
36. Hilker R., Voges J., Ghaemi M., Lehrke R., Rudolf J., Koulousakis A., et al. Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in parkinsonian humans. Mov Disord 2003, 18:41-48.
37. Strafella A.P., Sadikot A.F., Dagher A. Subthalamic deep brain stimulation does not induce striatal dopamine release in Parkinson's disease. Neuroreport 2003, 14:1287-1289.
38. Abosch A., Kapur S., Lang A.E., Hussey D., Sime E., Miyasaki J., et al. Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release. Neurosurgery 2003, 53:1095-1102. discussion 102-5.
39. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989, 12:366-375.
40. Kita H., Kitai S.T. Efferent projections of the subthalamic nucleus in the rat: light and electron microscopic analysis with the PHA-L method. J Comp Neurol 1987, 260:435-452.
41. Beurrier C., Bioulac B., Audin J., Hammond C. High-frequency stimulation produces a transient blockade of voltage-gated currents in subthalamic neurons. J Neurophysiol 2001, 85:1351-1356.
42. Magarinos-Ascone C., Pazo J.H., Macadar O., Buno W. High-frequency stimulation of the subthalamic nucleus silences subthalamic neurons: a possible cellular mechanism in Parkinson's disease. Neuroscience 2002, 115:1109-1117.
43. Gradinaru V., Mogri M., Thompson K.R., Henderson J.M., Deisseroth K. Optical deconstruction of parkinsonian neural circuitry. Science 2009, 324:354-359.
44. Feuerstein T.J., Kammerer M., Lucking C.H., Moser A. Selective GABA release as a mechanistic basis of high-frequency stimulation used for the treatment of neuropsychiatric diseases. Naunyn Schmiedebergs Arch Pharmacol 2011, 384:1-20.
45. Carlson J.D., Cleary D.R., Cetas J.S., Heinricher M.M., Burchiel K.J. Deep brain stimulation does not silence neurons in subthalamic nucleus in Parkinson's patients. J Neurophysiol 2010, 103:962-967.
46. McIntyre C.C., Savasta M., Walter B.L., Vitek J.L. How does deep brain stimulation work? Present understanding and future questions. J Clin Neurophysiol 2004, 21:40-50.
47. Wallace B.A., Ashkan K., Heise C.E., Foote K.D., Torres N., Mitrofanis J., et al. Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys. Brain 2007, 130:2129-2145.